AQST
Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. (AQST) has 9 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 17, 2026.
Insiders have net sold $226K over the trailing 6 months.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Daniel Barber
- Employees:142
- HQ:Warren, NJ, US
- IPO:2018-07-25
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$226K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$506.8M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Barber DanielFirst filing | President and CEO | Sale | 4,631 | $19K | Jul 17 | SEC ↗ |
Barber DanielFirst filing | President and CEO | Sale | 20,369 | $82K | Jul 17 | SEC ↗ |
Krop JulieFirst filing | Director | Sale | 25,000 | $125K | Jun 24 | SEC ↗ |
Related companies
Aquestive Therapeutics, Inc. is in the Healthcare sector.